ATAI Life Sciences N.V.
ATAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.68B
Close$
$-0.00
100% downside
Current Fair Value
100% downsideOvervalued by 100% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.68 Billion |
|---|---|
| Enterprise Value | $2.52 Billion |
| Dividend Yield | $6.00 (-) |
| Earnings per Share | $-2.91 |
| Beta | 1.57 |
| Outstanding Shares | 226,532,786 |
Return
| Return on Equity | -378.87% |
|---|---|
| Return on Assets | -252.35% |
| Return on Invested Capital | -60.29% |
Valuation & Multiples
| P/E Ratio | -2.42 |
|---|---|
| PEG | -13.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 562.85 |
| Enterprise Value to EBIT | -17.67 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$111,111
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$111,111
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.9551▲ 171.22% |
|---|---|
| Total Calls | 31,200▼ 97.22% |
| Total Puts | 61,000▼ 77.63% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 17.89%▼ 26.40% |
|---|---|
| Total Invested | $213.57M▼ 40.63% |
| Investors Holding | 97▼ 96.00% |
ESG Score
No data
About ATAI Life Sciences N.V.
35 employees